生熟三黄汤联合紫竭生肌膏在湿热下注型重度混合痔患者术后的作用

doi:10.3760/cma.j.issn.1007-1245.2024.02.018

摘要/Abstract

摘要：

目的　探讨生熟三黄汤联合紫竭生肌膏在湿热下注型重度混合痔术后的作用。方法　本文为随机对照试验。前瞻性选取2021年1月至2023年2月于商丘市中医院接受外剥内扎术治疗的188例湿热下注型重度混合痔患者作为研究对象，按照随机数字表法分为甲、乙、丙、丁4组，各47例。甲组男22例、女25例，年龄（45.26±8.32）岁，采用常规干预；乙组男21例、女26例，年龄（46.38±8.59）岁，采用常规干预+生熟三黄汤治疗；丙组男20例、女27例，年龄（47.13±8.67）岁，采用常规干预+紫竭生肌膏治疗；丁组男23例、女24例，年龄（45.89±8.45）岁，采用常规干预+生熟三黄汤+紫竭生肌膏治疗。对比4组患者临床指标和治疗前后炎症因子水平、肛门功能，并比较4组患者临床疗效和不良事件发生情况。计量资料采用t检验、F检验、SNK-q检验，计数资料采用χ²检验、秩和检验。结果　丁组疼痛时间、水肿时间、便血时间、肛门下坠时间、创面愈合时间［（7.15±1.59）d、（7.93±1.76）d、（6.23±1.38）d、（5.98±1.33）d、（11.56±2.57）d］均短于甲组［（8.97±1.99）d、（9.78±2.17）d、（7.82±1.74）d、（7.45±1.66）d、（16.16±3.59）d］、乙组［（8.06±1.79）d、（8.86±1.97）d、（7.05±1.57）d、（6.73±1.51）d、（14.39±3.24）d］、丙组［（7.93±1.76）d、（8.75±1.94）d、（6.91±1.54）d、（6.65±1.48）d、（13.38±2.97）d］，差异均有统计学意义（均P<0.05）。4组治疗后超敏C-反应蛋白（hs-CRP）、肿瘤坏死因子-α（TNF-α）及肛管高压带长度均低于治疗前，肛管收缩压、肛管静息压均高于治疗前，差异均有统计学意义（均P<0.05）。治疗后，丁组hs-CRP、TNF-α、肛管高压带长度［（11.15±2.48）mg/L、（25.12±5.58）ng/L、（2.47±0.54）cm］均低于甲组［（16.56±3.68）mg/L、（32.78±7.28）ng/L、（3.05±0.68）cm］、乙组［（13.17±2.93）mg/L、（28.56±6.35）ng/L、（2.77±0.62）cm］、丙组［（12.56±2.79）mg/L、（27.88±6.21）ng/L、（2.72±0.61）cm］，差异均有统计学意义（均P<0.05）。治疗后，丁组肛管收缩压、肛管静息压［（135.86±30.19）mmHg（1 mmHg=0.133 kPa）、（60.72±13.49）mmHg］均高于甲组［（111.38±24.75）mmHg、（49.76±11.06）mmHg］、乙组［（122.45±27.19）mmHg、（54.62±12.14）mmHg］、丙组［（123.57±27.46）mmHg、（55.35±12.31）mmHg］，差异均有统计学意义（均P<0.05）。丁组总有效率［95.74%（46/47）］高于甲组、乙组、丙组［70.21%（33/47）、80.85%（38/47）、82.98%（39/47）］，差异均有统计学意义（均P<0.05）。4组不良事件发生率比较，差异无统计学意义（P>0.05）。结论　生熟三黄汤联合紫竭生肌膏应用于湿热下注型重度混合痔术后疗效确切，可有效缓解患者临床症状，降低炎症因子水平，改善肛门功能，且安全性高。

关键词:

混合痔, 湿热下注型, 生熟三黄汤, 紫竭生肌膏

Abstract:

Objective　To explore the effect of Shengshu Sanhuang decoction combined with Zijie Shengji ointment on severe mixed hemorrhoids (damp heat bottom pour type) after surgery. Methods　This was a randomized controlled trial. A total of 188 patients with severe mixed hemorrhoids (damp heat bottom pour type) who underwent external peeling and internal ligation surgery in Shangqiu Hospital of Traditional Chinese Medicine from January 2021 to February 2023 were prospectively selected as the study objects, and were divided into group A, group B, group C, and group D according to the random number table method, with 47 cases in each group. In group A, 22 males and 25 females, aged (45.26±8.32) years, received routine intervention. In group B, 21 males and 26 females, aged (46.38±8.59) years, received routine intervention + Shengshu Sanhuang decoction. In group C, 20 males and 27 females, aged (47.13±8.67) years, received routine intervention + Zijie Shengji ointment. In group D, 23 males and 24 females, aged (45.89±8.45) years, received routine intervention + Shengshu Sanhuang decoction + Zijie Shengji ointment. Clinical indicators and levels of inflammatory factors and anal function before and after treatment were compared among the four groups, and the clinical efficacy and adverse events were compared among the four groups. t test, F test, and SNK-q test were used for the measurement data, and χ² test and rank sum test were used for the count data. Results　The pain time, edema time, bloody stool time, anal prolapse time, and wound healing time in group D [(7.15±1.59) d, (7.93±1.76) d, (6.23±1.38) d, (5.98±1.33) d, and (11.56±2.57) d] were shorter than those in group A [(8.97±1.99) d, (9.78±2.17) d, (7.82±1.74) d, (7.45±1.66) d, and (16.16±3.59) d], group B [(8.06±1.79) d, (8.86±1.97) d, (7.05±1.57) d, (6.73±1.51) d, and (14.39±3.24) d], and group C [(7.93±1.76) d, (8.75±1.94) d, (6.91±1.54) d, (6.65±1.48) d, and (13.38±2.97) d], with statistically significant differences (all P<0.05). After treatment, the levels of hypersensitive C-reactive protein (hs-CRP) and tumor necrosis factor-α (TNF-α) and anal high-pressure zone length in the four groups were all lower than those before treatment, while the anal canal systolic blood pressure and anal canal resting pressure were both higher than those before treatment, with statistically significant differences (all P<0.05). After treatment, the levels of hs-CRP and TNF-α and anal high-pressure zone length in group D [(11.15±2.48) mg/L, (25.12±5.58) ng/L, and (2.47±0.54) cm] were lower than those in group A [(16.56±3.68) mg/L, (32.78±7.28) ng/L, and (3.05±0.68) cm], group B [(13.17±2.93) mg/L, (28.56±6.35) ng/L, and (2.77±0.62) cm], and group C [(12.56±2.79) mg/L, (27.88±6.21) ng/L, and (2.72±0.61) cm], with statistically significant differences (all P<0.05). After treatment, the anal canal systolic blood pressure and anal canal resting pressure in group D [(135.86±30.19) mmHg (1 mmHg=0.133 kPa) and (60.72±13.49) mmHg] were higher than those in group A [(111.38±24.75) mmHg and (49.76±11.06) mmHg], group B [(122.45±27.19) mmHg and (54.62±12.14) mmHg], and group C [(123.57±27.46) mmHg and (55.35±12.31) mmHg], with statistically significant differences (all P<0.05). The total effective rate of group D [95.74% (46/47)] was higher than that of group A, B, and C [70.21% (33/47), 80.85% (38/47), and 82.98% (39/47)], with statistically significant differences (all P<0.05). There was no statistically significant difference in the incidence of adverse events among the four groups (P>0.05). Conclusion　Shengshu Sanhuang decoction combined with Zijie Shengji ointment has definite postoperative effect on patients with severe mixed hemorrhoids (damp heat bottom pour type) after surgery, which can effectively relieve the clinical symptoms, reduce the levels of inflammatory factors, and improve the anal function, with high safety.

Key words:

Mixed hemorrhoids, Damp heat bottom pour type, Shengshu Sanhuang decoction, Zijie Shengji ointment

中图分类号:

','1');return false;" target="_blank">

刘娜刘小转凡会霞王莹莹丁建华.

生熟三黄汤联合紫竭生肌膏在湿热下注型重度混合痔患者术后的作用 [J]. 国际医药卫生导报, 2024, 30(2): 269-274.

Liu Na, Liu Xiaozhuan, Fan Huixia, Wang Yingying, Ding Jianhua.

Effect of Shengshu Sanhuang decoction combined with Zijie Shengji ointment on patients with severe mixed hemorrhoids (damp heat bottom pour type) after surgery [J]. International Medicine and Health Guidance News, 2024, 30(2): 269-274.

参考文献

[1] Du B, Xu Z, Zhong X. Electroacupuncture for postoperative pain in mixed hemorrhoids: a meta-analysis[J].Medicine (Baltimore),2022,101(50):e32247. DOI:10.1097/MD.0000000000032247.
[2] Feng J, Cheng J, Xiang F. Management of intractable pain in patients treated with hemorrhoidectomy for mixed hemorrhoids[J].Ann Palliat Med,2021,10(1):479-483.DOI:10.21037/apm-20-2385.
[3] 龚璇,唐慧娟,蒋维连,等. 混合痔术后患者疼痛灾难化体验的质性研究[J]. 中国实用护理杂志,2022,38(8):612-617.DOI:10.3760/cma.j.cn211501-20210420-01174.
[4] Gao H, Cheng X, Liu R, et al. Clinical study of herbal mixture "Diding Oral Medicine" as an alternative to preventative antibiotics in perioperative hemorrhoids: a CARE-compliant article[J].Medicine (Baltimore),2021,100(18):e25661.DOI:10.1097/MD.0000000000025661.
[5] Xia W, Barazanchi AWH, MacFater WS, et al. Topical versus oral metronidazole after excisional hemorrhoidectomy: a double-blind randomized controlled trial[J].Dis Colon Rectum,2022,65(11):1362-1372.DOI:10.1097/DCR.0000000000002163.
[6] 张永丽,孙林梅,张翻翻. 解毒生肌汤雾化熏洗联合常规疗法治疗混合痔术后疼痛水肿患者疗效及对凝血指标的影响[J]. 血栓与止血学,2021,27(5):744-746.DOI:10.3969/j.issn.1009-6213.2021.05.009.
[7] 杜炳林,徐众淼. 止痛如神汤口服联合苦参汤熏洗治疗混合痔术后疼痛的临床疗效观察[J]. 世界中西医结合杂志,2021,16(2):339-341,345.DOI:10.13935/j.cnki.sjzx.210230.
[8] 李先元,高玲,王晓博,等. 生熟三黄汤对湿热下注型混合痔术后创面影响分析[J]. 环球中医药,2018,11(8):1226-1229.DOI:10.3969/j.issn.1674-1749.2018.08.012.
[9] 张建晓,苏云,勾鸣强,等. 秦艽苍术汤加味联合紫竭生肌膏用于混合痔术后患者创面修复效果观察[J]. 现代中西医结合杂志,2021,30(4):416-420.DOI:10.3969/j.issn.1008- 8849.2021.04.016.
[10] 中国中西医结合学会大肠肛门病专业委员会. 中国痔病诊疗指南(2020)[J]. 结直肠肛门外科,2020,26(5):519-533.DOI:10.19668/j.cnki.issn1674-0491.2020.05.001.
[11] 陈红风.中医外科学[M].4 版.北京:中国中医药出版社,2016:239.
[12] 中华人民共和国卫生部.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:152-155.
[13] Jia XQ, Cao WW, Quan LF, et al. Effect of high suspension and low incision surgery based on traditional ligation of Chinese medicine in treatment of mixed haemorrhoids: a multi-centre, randomized, single-blind, non-inferiority clinical trial[J].Chin J Integr Med,2021,27(9):649-655.DOI:10.1007/s11655-021-3329-2.
[14] Huang H, Wen K, Ding X, et al. The efficiency and safety of modified tissue-selecting therapy stapler combined with complete anal canal epithelial preservation operation in circumferential mixed hemorrhoids: a randomized controlled trial[J].Langenbecks Arch Surg,2023,408(1):332.DOI:10.1007/s00423-023-03081-2.
[15] Pei X, Song S, Li H, et al. Efficacy and safety of acupoint catgut embedding in treating postoperative pain of mixed hemorrhoids: a randomized controlled trial protocol[J].Medicine (Baltimore),2021,100(19):e25948.DOI:10.1097/MD.0000000000025948.
[16] 陆春霞,沈蓉蓉. 电针八髎穴结合西医常规疗法对混合痔术后疼痛及创面恢复的影响[J]. 国际中医中药杂志,2022,44(3):288-291.DOI:10.3760/cma.j.cn115398-20210619- 00166.
[17] 彭军良,沈雪峰,李利雄,等. 清热利湿止血方对湿热下注型环状混合痔术后疗效影响研究[J]. 现代中西医结合杂志,2021,30(25):2741-2745,2799.DOI:10.3969/j.issn.1008- 8849.2021.25.002.
[18] 王东宏,胡响当,刘洁. 凉血地黄汤联合消痔栓治疗混合痔术后并发症疗效观察及对创面愈合、炎症因子的影响[J]. 湖南中医药大学学报,2022,42(3):465-470.DOI:10.3969/j.issn.1674-070X.2022.03.022.
[19] 周艳,孙菲菲,张振凌,等. 基于网络药理学探讨熟地黄临床用于治疗贫血的潜在作用机制[J]. 中华中医药学刊,2021,39(5):179-183,后插31-后插33.DOI:10.13193/j.issn.1673-7717.2021.05.043.
[20] 杨飞霞,王玉,夏鹏飞,等. 当归补血汤化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析[J]. 中国中药杂志,2021,46(11):2677-2685.DOI:10.19540/j.cnki.cjcmm.20200828.201.
[21] 吉米丽汗·司马依,买买提明·努尔买买提,艾尼瓦尔·吾买尔,等. 黄连解毒汤抗新型冠状病毒肺炎的"中药-成分-靶点"调控网络研究[J]. 西北药学杂志,2021,36(5):763-769.DOI:10.3969/j.issn.1004-2407.2021.05.014.
[22] Lü D, Jiang Q, Zhang J, et al. Effect of baizhu (rhizoma atractylodis macrocephalae) extract on intestinal absorption of brucine and strychnine in vitro and in situ[J].J Tradit Chin Med,2020,40(4):562-570.DOI:10.19852/j.cnki.jtcm.2020.04.005.
[23] 古炳明,邬伟魁,刘佳,等. 地榆-茜草药对治疗子宫异常出血的网络药理学研究[J]. 云南民族大学学报(自然科学版),2023,32(1):13-18,44.DOI:10.3969/j.issn.1672-8513. 2023.01.003.
[24] 禇国华,孙婷,杨庆燕,等. 龙血竭紫草软膏在皮肤软组织扩张术后的运用研究 ——附38例临床资料[J]. 江苏中医药,2017,49(1):39-40.DOI:10.3969/j.issn.1672- 397X.2017.01.015.
[25] 朱亚玲,杨紫薇,高佳慧,等. 三七-白及药对作用机制的网络药理学分析[J]. 华侨大学学报(自然科学版),2020,41(4):501-509.DOI:10.11830/ISSN.1000-5013.201910048.
[26] 王猛,苏秀海,于文霞,等. 自制三黄紫草膏辅助治疗糖尿病足对创面愈合情况及血清5-HT、β-EP水平的影响观察[J]. 辽宁中医杂志,2021,48(5):98-100.DOI:10.13192/j.issn.1000-1719.2021.05.026.
[27] 孙嘉伟,刘欣,马媛媛,等. 龙血竭胶囊合九华膏对环状混合痔术后患者创面愈合、血清炎性因子和免疫功能的影响[J]. 现代生物医学进展,2020,20(19):3695-3698,3677.DOI:10.13241/j.cnki.pmb.2020.19.019.
[28] 潘慧莹,石先明,齐玥,等. 加味苦参汤联合紫归解毒膏对肛瘘术后创面愈合、肛肠动力学及血清TNF-α、IL-6、bFGF、TGF-β1水平的影响[J]. 现代生物医学进展,2022,22(2):388-391,363.DOI:10.13241/j.cnki.pmb.2022. 02.037.
[29] 吴本升,杨建华,王晓鹏,等. 紫黄生肌膏联合中药熏洗促进混合痔术后创面愈合的临床观察[J]. 中华中医药杂志,2019,34(1):419-422.